These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 15573840)
1. Prismatic correction in patients affected by age-related macular degeneration. Parodi MB; Toto L; Mastropasqua L; Depollo M; Ravalico G Clin Rehabil; 2004 Nov; 18(7):828-32. PubMed ID: 15573840 [TBL] [Abstract][Full Text] [Related]
2. A randomized controlled trial to determine the effectiveness of prism spectacles for patients with age-related macular degeneration. Smith HJ; Dickinson CM; Cacho I; Reeves BC; Harper RA Arch Ophthalmol; 2005 Aug; 123(8):1042-50. PubMed ID: 16087836 [TBL] [Abstract][Full Text] [Related]
4. [Prismatic treatment in low-vision rehabilitation of patients with age-related macular degeneration]. Vettard S; Dubois E; Quaranta M; Mauget-Faÿsse M J Fr Ophtalmol; 2004 Jun; 27(6 Pt 1):589-96. PubMed ID: 15343117 [TBL] [Abstract][Full Text] [Related]
5. Improvement of visual acuity by refraction in a low-vision population. Sunness JS; El Annan J Ophthalmology; 2010 Jul; 117(7):1442-6. PubMed ID: 20231036 [TBL] [Abstract][Full Text] [Related]
6. Self-recognition of recurrences among patients with exudative age-related macular degeneration. Kim JH; Chang YS; Kim JW; Lee DW; Han JI; Kim CG Clin Exp Optom; 2016 Jan; 99(1):56-60. PubMed ID: 26875854 [TBL] [Abstract][Full Text] [Related]
7. Intereye difference in exudative age-related macular degeneration with minimally classic or occult subfoveal neovascularization after unilateral intravitreal injection of triamcinolone acetonide. Jonas JB; Spandau UH; Harder B; Vossmerbaeumer U; Kamppeter BA Am J Ophthalmol; 2005 Jun; 139(6):1073-9. PubMed ID: 15953439 [TBL] [Abstract][Full Text] [Related]
8. Comparison of early retreatment with the standard regimen in verteporfin therapy of neovascular age-related macular degeneration. Michels S; Wachtlin J; Gamulescu MA; Heimann H; Prünte C; Inhoffen W; Krebs I; Schmidt-Erfurth U Ophthalmology; 2005 Dec; 112(12):2070-5. PubMed ID: 16225928 [TBL] [Abstract][Full Text] [Related]
9. Randomized, double-blind, placebo-controlled study of zeaxanthin and visual function in patients with atrophic age-related macular degeneration: the Zeaxanthin and Visual Function Study (ZVF) FDA IND #78, 973. Richer SP; Stiles W; Graham-Hoffman K; Levin M; Ruskin D; Wrobel J; Park DW; Thomas C Optometry; 2011 Nov; 82(11):667-680.e6. PubMed ID: 22027699 [TBL] [Abstract][Full Text] [Related]
10. Change in visual function after macular translocation with 360 degrees retinectomy for neovascular age-related macular degeneration. Mruthyunjaya P; Stinnett SS; Toth CA Ophthalmology; 2004 Sep; 111(9):1715-24. PubMed ID: 15350328 [TBL] [Abstract][Full Text] [Related]
11. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group. Arch Ophthalmol; 1999 Oct; 117(10):1329-45. PubMed ID: 10532441 [TBL] [Abstract][Full Text] [Related]
12. Argon green vs. krypton red laser photocoagulation for extrafoveal choroidal neovascularization secondary to age-related macular degeneration: 3-year results of a multicentre randomized trial. Canadian Ophthalmology Study Group. Willan AR; Cruess AF; Ballantyne M Can J Ophthalmol; 1996 Feb; 31(1):11-7. PubMed ID: 8925479 [TBL] [Abstract][Full Text] [Related]
14. Effect of bifocal and prismatic bifocal spectacles on myopia progression in children: three-year results of a randomized clinical trial. Cheng D; Woo GC; Drobe B; Schmid KL JAMA Ophthalmol; 2014 Mar; 132(3):258-64. PubMed ID: 24435660 [TBL] [Abstract][Full Text] [Related]
15. Three-year safety and visual acuity results of epimacular 90 strontium/90 yttrium brachytherapy with bevacizumab for the treatment of subfoveal choroidal neovascularization secondary to age-related macular degeneration. Avila MP; Farah ME; Santos A; Carla L; Fuji G; Rossi J; Nau J Retina; 2012 Jan; 32(1):10-8. PubMed ID: 21817963 [TBL] [Abstract][Full Text] [Related]
16. Rehabilitation of the visually handicapped with advanced macular degeneration. A follow-up study at the Low Vision Clinic, Department of Ophthalmology, University of Linköping. Nilsson UL; Nilsson SE Doc Ophthalmol; 1986 May; 62(4):345-67. PubMed ID: 2942377 [TBL] [Abstract][Full Text] [Related]
17. Gene therapy with recombinant adeno-associated vectors for neovascular age-related macular degeneration: 1 year follow-up of a phase 1 randomised clinical trial. Rakoczy EP; Lai CM; Magno AL; Wikstrom ME; French MA; Pierce CM; Schwartz SD; Blumenkranz MS; Chalberg TW; Degli-Esposti MA; Constable IJ Lancet; 2015 Dec; 386(10011):2395-403. PubMed ID: 26431823 [TBL] [Abstract][Full Text] [Related]
18. One-year outcomes of less frequent bevacizumab in age-related macular degeneration. Sonmez K; Sonmez PA; Ozkan SS; Atmaca LS Retina; 2011 Apr; 31(4):645-53. PubMed ID: 21358363 [TBL] [Abstract][Full Text] [Related]
19. Clinical experience with the Ben-Sira teledioptric system for use in age-related macular degeneration. Mayer A Ger J Ophthalmol; 1996 Jul; 5(4):229-32. PubMed ID: 8854107 [TBL] [Abstract][Full Text] [Related]
20. Image relocation with prisms in patients with age-related macular degeneration. Al-Karmi R; Markowitz SN Can J Ophthalmol; 2006 Jun; 41(3):313-8. PubMed ID: 16767185 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]